Both in Biotechnology
Cullinan Therapeutics vs Ginkgo Bioworks Holdings
Over the past year CGEM returned +101.7% and DNA returned −15.9%; their daily moves had a correlation of 0.25.
CGEM +101.7% DNA −15.9%Growth of $1, one year, split-adjusted
| Metric | CGEM | DNA |
|---|---|---|
| Price | $15.75 | $10.76 |
| Market cap | $1.01B | $724.6M |
| Today | +5.49% | +9.24% |
| 1 month | −1.8% | −28.2% |
| 6 months | +5.4% | +10.8% |
| Year to date | +52.2% | +29.5% |
| 1 year | +81.9% | −17.2% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.5× |
| Net cash | $334.5M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 75.9% | 128.2% |
| Short % of float | 14.3% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).